FDA to Decide on Pfizer Vaccine Booster Shots Without Hearing From Expert Panel

FDA to Decide on Pfizer Vaccine Booster Shots Without Hearing From Expert Panel
A vial of the Pfizer-BioNTech COVID-19 vaccine is seen in a file photograph. Justin Sullivan/Getty Images
Zachary Stieber
By Zachary Stieber, Senior Reporter
Updated:

U.S. drug regulators will decide whether to authorize booster doses of Pfizer’s COVID-19 vaccine for all Americans aged 16 or older without convening its expert vaccine advisory panel, the Food and Drug Administration (FDA) confirmed to The Epoch Times on Nov. 17.

The FDA’s acting head and other top Biden administration officials said earlier in 2021 that vaccine booster doses should be given to everyone because of waning vaccine efficacy against the virus that causes COVID-19. But the advisory panel recommended vaccine boosters for only certain groups, arguing that the data didn’t support the widespread administration of second and third vaccine doses.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics